Central nervous system pathology progresses independently of KC and CXCR2 in globoid-cell leukodystrophy.
Globoid-cell Leukodystrophy (GLD; Krabbe's disease) is a rapidly progressing inherited demyelinating disease caused by a deficiency of the lysosomal enzyme Galactosylceramidase (GALC). Deficiency of GALC leads to altered catabolism of galactosylceramide and the cytotoxic lipid, galactosylsphing...
Main Authors: | Adarsh S Reddy, Jigisha R Patel, Carole Vogler, Robyn S Klein, Mark S Sands |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23755134/pdf/?tool=EBI |
Similar Items
-
Bone Marrow Transplantation Alters the Tremor Phenotype in the Murine Model of Globoid-Cell Leukodystrophy
by: Adarsh S. Reddy, et al.
Published: (2012-01-01) -
CNS-targeted Gene Therapy in Globoid Cell Leukodystrophy
by: Dar-Shong Lin, et al.
Published: (2013) -
Psychosine, the cytotoxic sphingolipid that accumulates in globoid cell leukodystrophy, alters membrane architecture
by: Jacqueline A. Hawkins-Salsbury, et al.
Published: (2013-12-01) -
Ex vivo gene therapy approaches for the treatment of globoid cell leukodystrophy
by: Visigalli, Ilaria
Published: (2009) -
Globoid cell leukodystrophy (Krabbe's disease): isolation of myelin with normal glycolipid composition
by: YOSHIKATSU ETO, et al.
Published: (1970-09-01)